Focus: Minerva Surgical is a public women's health company specializing in endometrial ablation and hysteroscopic tissue resection systems for menorrhagia and uterine fibroids. The company operates as a focused medical device manufacturer in the surgical gynecology space.
Profile data last refreshed 33m ago · AI intelligence enriched 2mo ago
Growing — net +6 jobs in 30d
6 jobs added vs 0 removed. Steady team buildout.
Best suited for professionals seeking deep specialization in surgical devices and women's health, but only if hiring resumes; current zero openings is a red flag.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Flagship device system with ongoing clinical trial support for the company's core indication.
Help build intelligence for Minerva Surgical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Minerva Surgical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Addresses complementary gynecological condition with expanding market potential.
Alternative heat transfer ablation platform targeting the same menorrhagia patient population.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo